OTHER NEWS - July 24, 1996

Glaxo, BioChem Accused of 3TC Patent Infringement: Glaxo Wellcome and Biochem Pharma Inc.’s sales of the HIV drug 3TC are infringing on a patent issued to Emory University, school officials and lawyers said. Sold in the U.S. as Epivir, 3TC is an important component of the new AIDS “cocktail therapies” that combine two or more drugs. The U.S. Patent and Trademark Office awarded the patent rights to Emory. London-based Glaxo said it believes Emory’s patent is invalid. Quebec-based Biochem Pharma officials weren’t immediately available.